- Home
- FCAP vs CYBN Comparison
FCAP vs CYBN Comparison
Compare FCAP & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCAP
- CYBN
- Stock Information
- Founded
- FCAP 1891
- CYBN 2019
- Country
- FCAP United States
- CYBN Canada
- Employees
- FCAP N/A
- CYBN N/A
- Industry
- FCAP Savings Institutions
- CYBN Pharmaceuticals and Biotechnology
- Sector
- FCAP Finance
- CYBN Health Care
- Exchange
- FCAP Nasdaq
- CYBN Nasdaq
- Market Cap
- FCAP 125.9M
- CYBN 147.4M
- IPO Year
- FCAP 1999
- CYBN N/A
- Fundamental
- Price
- FCAP $44.01
- CYBN $6.08
- Analyst Decision
- FCAP
- CYBN Strong Buy
- Analyst Count
- FCAP 0
- CYBN 3
- Target Price
- FCAP N/A
- CYBN $85.00
- AVG Volume (30 Days)
- FCAP 3.6K
- CYBN 1.1M
- Earning Date
- FCAP 10-24-2025
- CYBN 11-17-2025
- Dividend Yield
- FCAP 2.79%
- CYBN N/A
- EPS Growth
- FCAP 25.19
- CYBN N/A
- EPS
- FCAP 4.41
- CYBN N/A
- Revenue
- FCAP $47,323,000.00
- CYBN N/A
- Revenue This Year
- FCAP N/A
- CYBN N/A
- Revenue Next Year
- FCAP N/A
- CYBN N/A
- P/E Ratio
- FCAP $9.69
- CYBN N/A
- Revenue Growth
- FCAP 15.22
- CYBN N/A
- 52 Week Low
- FCAP $28.50
- CYBN $4.81
- 52 Week High
- FCAP $53.85
- CYBN $13.88
- Technical
- Relative Strength Index (RSI)
- FCAP 57.27
- CYBN 46.11
- Support Level
- FCAP $42.71
- CYBN $6.86
- Resistance Level
- FCAP $44.00
- CYBN $8.00
- Average True Range (ATR)
- FCAP 0.80
- CYBN 0.49
- MACD
- FCAP 0.20
- CYBN -0.04
- Stochastic Oscillator
- FCAP 100.00
- CYBN 18.56
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.